Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in VERA — Vera Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in VERA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,397,739
+$441,495 QoQ
Shares Held
195,706
-1.0% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 217 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in VERA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. VERA ranks #43 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VERA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,397,739 195,706
2026-03-31 $7,956,244 197,769
2025-12-31 $10,277,538 202,953
2025-09-30 $2,391,111 82,282
2025-06-30 $3,606,985 153,098
2025-03-31 $2,354,269 98,013
2024-12-31 $3,387,681 80,106
2024-09-30 $2,721,569 61,574
2024-06-30 $1,992,792 55,080
2024-03-31 $1,370,223 31,777
2023-12-31 $327,855 21,317